Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Mellow

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Psychiatry|October 1, 1987
CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjectsT Sunderland, D R Rubinow, P N Tariot, et al.
Psychiatry Research|July 1, 1989
Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjectsB A Lawlor, T Sunderland, J L Hill, et al.
Psychopharmacology|January 1, 1989
Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's diseaseA M Mellow, T Sunderland, R M Cohen, et al.
Archives of General Psychiatry|May 1, 1987
L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibitionP N Tariot, R M Cohen, T Sunderland, et al.
Archives of General Psychiatry|August 1, 1994
High-dose selegiline in treatment-resistant older depressive patientsT Sunderland, R M Cohen, S Molchan, et al.
Psychoneuroendocrinology|January 1, 1993
CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measuresS E Molchan, J L Hill, R A Martinez, et al.
The American Journal of Psychiatry|August 1, 1988
A new scale for the assessment of depressed mood in demented patientsT Sunderland, I S Alterman, D Yount, et al.
Neurology|November 23, 2000
Treatment of agitation in AD: a randomized, placebo-controlled clinical trialL Teri, R G Logsdon, E Peskind, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Psychiatry|October 1, 1987
CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjectsT Sunderland, D R Rubinow, P N Tariot, et al.
Psychiatry Research|July 1, 1989
Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjectsB A Lawlor, T Sunderland, J L Hill, et al.
Psychopharmacology|January 1, 1989
Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's diseaseA M Mellow, T Sunderland, R M Cohen, et al.
Archives of General Psychiatry|May 1, 1987
L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibitionP N Tariot, R M Cohen, T Sunderland, et al.
Archives of General Psychiatry|August 1, 1994
High-dose selegiline in treatment-resistant older depressive patientsT Sunderland, R M Cohen, S Molchan, et al.
Psychoneuroendocrinology|January 1, 1993
CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measuresS E Molchan, J L Hill, R A Martinez, et al.
The American Journal of Psychiatry|August 1, 1988
A new scale for the assessment of depressed mood in demented patientsT Sunderland, I S Alterman, D Yount, et al.
Neurology|November 23, 2000
Treatment of agitation in AD: a randomized, placebo-controlled clinical trialL Teri, R G Logsdon, E Peskind, et al.
Pageof 5